ArticleInfection & chemotherapy2023

An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care

Phahol Sarojvisut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.